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Autoantibodies against Muscarinic Type 3 Receptor in
Sjögren’s Syndrome Inhibit Aquaporin 5 Trafficking
Byung Ha Lee1, Adrienne E. Gauna1, Geidys Perez1, Yun-jong Park1, Kaleb M. Pauley2, Toshihisa Kawai3,
Seunghee Cha1*
1 Department of Oral and Maxillofacial Diagnostic Sciences, University of Florida College of Dentistry, Gainesville, Florida, United States of America, 2 Department of
Science and Mathematics, Cedarville University College of Arts and Sciences, Cedarville, Ohio, United States of America, 3 Department of Immunology, The Forsyth
Institute, Cambridge, Massachusetts, United States of America

Abstract
Sjögren’s syndrome (SjS) is a chronic autoimmune disease that mainly targets the salivary and lacrimal glands. It has been
controversial whether anti-muscarinic type 3 receptor (a-M3R) autoantibodies in patients with SjS inhibit intracellular
trafficking of aquaporin-5 (AQP5), water transport protein, leading to secretory dysfunction. To address this issue, GFPtagged human AQP5 was overexpressed in human salivary gland cells (HSG-hAQP5) and monitored AQP5 trafficking to the
plasma membrane following carbachol (CCh, M3R agonist) stimulation. AQP5 trafficking was indeed mediated by M3R
stimulation, shown in partial blockage of trafficking by M3R-antagonist 4-DAMP. HSG-hAQP5 pre-incubated with SjS plasma
for 24 hours significantly reduced AQP5 trafficking with CCh, compared with HSG-hAQP5 pre-incubated with healthy
control (HC) plasma. This inhibition was confirmed by monoclonal a-M3R antibody and pre-absorbed plasma. Interestingly,
HSG-hAQP5 pre-incubated with SjS plasma showed no change in cell volume, compared to the cells incubated with HC
plasma showing shrinkage by twenty percent after CCh-stimulation. Our findings clearly indicate that binding of anti-M3R
autoantibodies to the receptor, which was verified by immunoprecipitation, suppresses AQP5 trafficking to the membrane
and contribute to impaired fluid secretion in SjS. Our current study urges further investigations of clinical associations
between SjS symptoms, such as degree of secretory dysfunction, cognitive impairment, and/or bladder irritation, and
different profiles (titers, isotypes, and/or specificity) of anti-M3R autoantibodies in individuals with SjS.
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acetylcholine or carbachol, and thus mediate Ca2+ release from
intracellular calcium storage [11]. This elevated intracellular
concentration of Ca2+ was shown to induce saliva secretion from
rat parotid acinar cells [12,13]. One of the main water transport
proteins involving saliva secretion in response to increased
concentration of Ca2+ is aquaporin 5 (AQP5) [13,14]. It has been
shown that rat AQP5 expressed in human salivary gland (HSG)
cells translocate to the plasma membrane in response to increased
intracellular Ca2+concentration [15].
Aquaporin proteins are widely distributed throughout the
organs, playing various roles in the body as well as in salivation.
Among the 13 known aquaporin proteins, AQP5 is detected in
lungs, cornea, salivary, and lacrimal glands [16]. In the salivary
glands, AQP5 is localized at the apical membrane of serous-type
acinar cells [17]. AQP5 knockout studies in mice confirmed the
critical role of AQP5 in water secretion in the salivary gland acinar
cells [18,19]. However, whether abnormal trafficking of AQP5
contributes to the loss of secretory function in SjS as a result of
antagonist effects of anti-M3R autoantibodies on the receptor is
still largely controversial. Studies indicate that different AQP5
staining methods on the salivary or lacrimal glands of SjS patients
have produced inconsistent results; abnormal distribution/selec-

Introduction
Sjögren’s syndrome (SjS), a systemic autoimmune disease
primarily targeting the salivary and lacrimal glands, results in
severe dry mouth and dry eyes [1,2]. Despite endeavors to define
the environmental, genetic, physiological and immunological
causes for SjS onset and progression, underlying etiologies remain
poorly understood. Possible mechanisms for dry mouth and dry
eyes include epithelial cell apoptosis by autoreactive T- or Blymphocytes infiltrating the glands and pro-inflammatory cytokines [3,4]. Another important mechanism underlying secretory
dysfunction in SjS involves inhibitory roles of autoantibodies to the
acetylcholine muscarinic type 3 receptor (M3R), which is critical
for fluid secretion from acinar cells. It has been reported that
autoantibodies against M3R suppress secretion by functioning as
an antagonist for the receptor [5,6,7,8]. In addition, studies have
demonstrated acute inhibition of parasympathetic neurotransmission in bladder smooth muscle in the presence of SjS anti-M3R
autoantibodies [9,10].
M3R belongs to the subfamily of G protein coupled receptors
(GPCR), which includes subtypes of M1R-M5R. M3R coupled to
Gq/11 and can initiate the phosphatidylinositol triphosphate
cascade through the binding of muscarinic agonists such as
PLOS ONE | www.plosone.org
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tive defect for AQP5 trafficking to apical membrane vs. no
difference in the distribution and density of AQP5 in patients with
primary SjS [20,21,22]. Studies with SjS mouse models have also
shown conflicting observations with respect to AQP5 distribution
in the salivary glands [23,24].
Therefore, we investigated whether AQP5 trafficking is altered
in SjS due to the presence of anti-M3R autoantibodies by
monitoring GFP-tagged human AQP5 trafficking in cells preincubated with SjS plasma or sera under a confocal imaging
system. We hypothesized that anti-M3R autoantibodies inhibit
AQP5 trafficking to the apical membrane, thus contributing to
secretory dysfunction in SjS.

Immunofluorescent staining
Cells were fixed with 4% paraformaldehyde for 15 minutes or
with PBS in case of live cell staining. Primary and secondary
antibodies were incubated for 90 min. and 30 min., respectively,
at room temperature in 1% BSA in PBS. M3R protein was
detected with rabbit anti-M3R antibodies (Santa Cruz Biotechnology) (1:100 dilution) or mouse monoclonal anti-hM3R
loop2 antibody (1:100 dilution) as a primary antibody and Alexa
Fluor 568-labeled goat anti-rabbit or mouse IgG (Molecular
Probes) (1:400 dilution) as a secondary antibody. For IgG
detection, plasma samples (1:500) from healthy controls or SjS
patients for the fixed cells or purified IgG or pre-absorbed plasma
for live cell staining were used as a primary antibody. Secondary
antibody was Alexa Fluor 488-labeled goat anti-human IgG (1:400
dilution) from Molecular Probes. Images were observed at a 200X
or a 400X magnification using a Zeiss Axiovert 200M microscope
equipped with a Zeiss AxioCam MRm camera and obtained with
AxioVs40 software (Ver. 4.7.1.0, Zeiss). For IgG purification, five
plasma samples in each group were pooled and purified using
PureProteomeTM Protein G Magnetic Beads (Millopore).

Materials and Methods
HSG cell culture and transfection
Human submandibular gland (HSG) cell line, originally from
NIDCR, was provided by Dr. Joseph Katz in Oral Medicine at the
College of Dentistry [25]. The cells were maintained in Dulbecco’s
modified Eagle’s medium supplemented with 10% fetal calf serum,
100 units/ml of penicillin, and 100 mg/ml of streptomycin (Life
Technologies) at 37uC. For transfection, 50,000 HSG cells were
seeded in each well of 8-chamber-well slides (BD bioscience) and
cultured in growth media overnight. The cells were transfected
with LipofectamineTM 2000 (Invitrogen), according to manufacturer’s protocol, with rhAQP5 expression vector (0.5 mg) or
control GFP expression vector (0.5 mg) diluted in Opti-MEM
serum-free medium (Invitrogen). Transfected HSG cells were
incubated for 48 hours for the maximum transfection efficiency.
To block M1R or M3R on HSG cells, pirenzepine dihydrochloride (pirenzepine, M1R antagonist, Sigma-Aldrich) or 4-diphenylacetoxy-N-methyl-piperidine (4-DAMP, M3R antagonist, Ascent
Scientific LLC) at a 10 mM concentration was treated for
10 minutes. For the M3R stimulation on HSG cells, 100 mM of
carbamylcholine chloride (carbachol, M3R agonist, Sigma-Aldrich) was treated for 10 minutes.

Western blotting and immunoprecipitation
For total cell lysates, cells were lysed in lysis buffer (50 mM TrisHCl pH 7.5, 2 mM EDTA, 500 mM NaCl, and 1% NP-40)
supplemented with protease inhibitors (complete Mini, Roche). To
purify membrane fraction, Mem-PER Membrane Protein Extraction Kit (Pierce) was used according to manufacturer’s instruction.
Protein concentrations of cell lysates were determined by the
Bradford protein assay, and 1 mg of each lysate preparation was
separated by electrophoresis through 4–20% linear gradient TrisHCl precast gels (Bio-Rad Laboratories). For immunoprecipitation, pooled HC or SjS plasma were mixed with and PureProteomeTM protein G magnetic Beads (Millipore) and washed
five times according to manufacturer’s instruction, then, mixed
with M3R overexpressing HSG cell lysates and incubated
overnight at 4uC. To overexpress M3R on HSG cells, 3xhemagglutinin (3x-HA) tagged M3R expression vector (UMR
cDNA Resource Center) was transfected into HSG cells. For
western blotting, protein samples were resolved by SDS-PAGE
then transferred to PVDF membranes (0.2 mm pore size, Bio-Rad
Laboratories) using a Pierce Fast Semi-Dry Blotter (Thermo
Scientific) and the membranes probed with either goat anti-human
b-actin (Sigma-Aldrich) or goat anti-pan-cadherin (Santa Cruz
Biotechnology) or rabbit anti-human AQP5 (Santa Cruz Biotechnology) or mouse anti-HA (Sigma-Aldrich) antibodies. The
membranes were incubated with appropriate HRP-conjugated
secondary antibodies. The signals were visualized using the ECL
Advance Detection Kit (Thermo Scientific).

Construction of GFP-tagged human aquaporin 5
(rhAQP5)
Messenger RNA from HSG cells was used to clone hAQP5 by
reverse transcription polymerase chain reaction (RT-PCR). RTPCR was performed using primers as follows: (F) 59-CTCGAGATGAAGAAGGAGG-39
and
(R)
59-GAATTCTATAGCGGGTGGTCAG-39. PCR conditions were 5 min at
95uC, (30 s at 95uC, 30 s at 57uC, and 30 s at 72uC) 630 times,
and 7 min at 72uC. Purified RT-PCR product was sequenced and
compared with NCBI database using nucleotide BLAST and
cloned into multiple cloning site of pAcGFP1-N1 GFP expression
vector (Clontech).

Confocal Microscopy
HSG cells (26105 cells/well) were grown on Delta T culture
dish (0.17 mm thick, Bioptechs) in a 6-well plate overnight.
rhAQP5 expression vector (0.5 mg) was transfected into the cells in
each well by LipofectamineTM 2000 (Invitrogen). At 48 hour of
post-transfection, HSG cells with hAQP5-GFP transfection were
pre-incubated with plasma from five HC or five SjS patients for
24 hours and stimulated with CCh (100 mM). Live-cell images
were acquired with a spinning disk confocal connected to a Leica
DMIRB microscope with a 63X oil-immersion objective, using
a cascade-cooled EMCCD camera (Photometrics, Tucson, AZ,
USA), under the control of mManager open-source software
(http://www.micro-manager.org/University of California San
Francisco, CA, USA). Throughout the imaging process, the cells
were maintained on a temperature-controlled stage at 37uC, and

Patient and control subjects
Five plasma samples from female patients with primary SjS
selected for positive anti-M3R IgG at a plasma titration of 1/500.
The patients were selected based on the modified EuropeanAmerican diagnostic criteria [26]. Patients’ demographic, clinical
and laboratory characteristics are summarized in Table 1. Five
gender-matched healthy donors with no history of autoimmune
diseases were included as healthy controls. This study was
approved by the University of Florida Institutional Review Board,
and a written permission was obtained from all who participated
in the study.

PLOS ONE | www.plosone.org
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Table 1. Demographics and clinical data for patients.

Salivary flow
(ml/min)

Subject

Sex

Age (Years)

Diagnosis

Medications

SSA*

SSB*

Biopsy/focus score

SjS-1

F

65

Primary SjS

Cevimeline

Neg*

Neg

Pos*, 7

0.293

*

SjS-9

F

77

Primary SjS

None

Pos

N/A

N/A

0.03

SjS-15

F

65

Primary SjS

Prednisone; Hydroxychloroquine;
Methotrexate

Pos

Neg

N/A

0.011

SjS-16

F

78

Primary SjS

Hydroxychloroquine

Pos

Pos

Pos, 5

0.042

SjS-26

F

32

Primary SjS

Hydroxychloroquine; Cyclosporin
opthalmic

Pos

Neg

Pos, 3

0.06

*N/A, no data available; Pos, positive; Neg, Negative; SSA, anti-Lo antibodies; SSB, anti-La antibodies.
doi:10.1371/journal.pone.0053113.t001

protein on HSG cells, we performed immunofluorescence staining
on HSG cells by using a commercially available polyclonal
antibody specific for M3R or monoclonal antibody against 2nd
extracellular loop of human M3R. Figure 1A shows the expression
of M3R on the HSG cell membrane (red signal) detected by
commercially available anti-M3R antibodies (a, b) or monoclonal
antibody (c) at 6200 (a) or 6400 (b, c) magnifications. After
confirming the presence of M3R on HSG cells, GFP-tagged
recombinant human AQP5 expression vector (rhAQP5) was
constructed and transfected into HSG cells (rhAQP5-HSG) to
monitor AQP5 trafficking. Figure 1B-(a) shows expression of
hAQP5 in total cell lysates from HSG or rhAQP5-HSG cells at
48-hour post transfection by western blotting. The expression was
significantly increased after transfection in comparison with
endogenous expression of AQP5 in non-transfected HSG cells.
Next, we tested hAQP5 trafficking in rhAQP5-HSG cells following
carbachol (CCh, an acetylcholine receptor agonist) stimulation. To
compare the hAQP5 expression on the membrane with or without
CCh treatment on rhAQP5-HSG cells, membrane fractions were
isolated and hAQP5 protein expressions were detected by western
blotting (Figure 1B-(b)). Increased expression of hAQP5 in the
membrane of CCh treated rhAQP5-HSG cells confirmed translocation of hAQP5 from cytosol into membrane.
To visualize the hAQP5 translocation to HSG cell plasma
membrane following CCh stimulation, HSG cells were seeded
(50,000 cells/well) on an 8-well chamber slide and transfected with
control GFP or rhAQP5 vector, cells were stimulated with or
without CCh (100 mM) for 10 minutes. Then, HSG cells were
fixed and observed under the microscope at a 6400 magnification.
As shown in Figure 1C, control vector transfected HSG cells
uniformly expressed GFP signal and showed no changes in GFP
signal followed by CCh treatment (Figure 1C-(a)) and rhAQP5HSG cells showed rhAQP5-GFP expression mainly in cytosolic
region (Figures 1C-(b)). However, CCh induced rhAQP5-HSG
cells showed hAQP5 trafficking to the membrane (Figure 1C-(c)),
which indicated as enhanced green signals on the cell membrane.
This confirmed that agonist CCh stimulation on muscarinic
receptors (MRs) translocates hAQP5 to the plasma membrane of
HSG cells (CCD captured real-time image shown in Figure S2).

observed at 30 second intervals up to 30 min. with 1/250 second
fixed exposure time. Representative images were constructed using
the image analysis software ImageJ (http://rsb.info.nih.gov/ij/).

Image Analyses
Representative confocal microscopy imagesshowing AQP5
trafficking in HSG cells were converted into ‘Fire’ 3D LUT
(lookup tables) setting in ImageJ software for the signal quantification. GFP signal that was above the set fluorescent signal
threshold ($80, red or yellow colorin bar chart) was considered as
positive for the analysis. Signal above the threshold along the
membrane was calculated and presented as K, which is percentage
of positive signal on the membrane, based on the following
formula: positive signal on the membrane divided by positive
signal on the total circumference length of membrane.

Measurement of intracellular calcium release in HSG cells
HSG cells that were plated in 96 well plates one day before
(20,000 cells/well) were pre-incubated with IgG fraction (10 mg/
ml) from HC or SjS plasma, or monoclonal anti-M3R antibody
(10 mg/ml) for 24 hours. Then, HSG cells were stained and
incubated for calcium release assay using Fluo-4 NW Calcium
Assay Kits (Molecular ProbesTM) according to manufacturer’s
instruction. Carbachol (CCh, 100 mM) or Ionomycin (positive
control, 100 mM) was applied to HSG cells to stimulate calcium
release in HSG cells. Relative intracellular calcium concentration
[Ca2+] was measured as fluorescence signal within a minute using
Spectramax M5 Microplate Reader (Molecular devices). The
fluorescence detected using instrument settings appropriate for
excitation at 494 nm and emission at 515 nm and analyzed by
using softmax pro 4.8 software.

Statistical Analyses
The data are expressed as the mean 6 SEM. Statistical
evaluation was determined by using t-test by the GraphPad Prism
software (GraphPad Software). The p value less than 0.05 was
considered statistically significant.

Results

Pre-incubation of a M3R-specific antagonist, 4-DAMP,
inhibited CCh-induced hAQP5 trafficking in rhAQP5transfected HSG cells

Muscarinic receptor agonist, carbachol, induces rhAQP5
trafficking in human salivary gland (HSG) cells
The expression of M3R mRNA in human salivary gland (HSG)
cells was confirmed in previous studies [27,28]. We also screened
all five muscarinic receptor expressions (M1R-M5R) in HSG cells
and confirmed weak mRNA expression of M1R and major
expression of M3R (Figure S1). To confirm the expression of M3R
PLOS ONE | www.plosone.org

After confirmation of hAQP5 trafficking to HSG cell membrane
following CCh treatment, we next sought to determine if hAQP5
trafficking would be inhibited or interfered by the blocking M3R
via a M3R-specific antagonist. Among the muscarinic receptor
3
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contrast, cells pre-incubated with M1R antagonist prenzepine still
exhibited strong signals in the membrane but when treated in
combination with 4-DAMP, it reduced the signal in the
membrane. These results strongly indicate that although other
MR subtypes, such as M1R, are present on HSG cells, hAQP5
trafficking is mainly mediated through M3R stimulation with
CCh.

SjS IgG binds to M3R and other surface antigens on HSG
cells
To investigate the roles of anti-M3R autoantibodies in
regulating AQP5 trafficking, five healthy control (HC) or five
SjS patient plasma samples were selected following screening
(Table 1). All five SjS plasma samples obtained from female
patients with primary SjS were positive for IgG that binds to HSG
cells at a plasma titration of 1/500. Only HSG cells pre-incubated
with SjS plasma showed positive IgG staining (Figure 3A-(b) and
(e)) while HSG cells incubated with HC plasma were negative
(Figure 3A-(a)). Furthermore, HSG cells pre-incubated with SjS
plasma showed co-localization of IgG and M3R as indicated in
Figure 3A (yellow in the merged image). However, when this
plasma sample was pre-absorbed for 24 hours with HSG cells, IgG
binding was no longer detected, indicating that SjS plasma
contains anti-M3R autoantibodies. In addition, cells pre-incubated
with IgG-depleted plasma, which a byproduct of IgG purification
showed negative IgG staining on the surface as expected.
Interestingly, HSG cells pre-incubated with a SjS plasma sample
showed green color in a merged image, indicating presence of IgG
specific to other unidentified antigens besides M3R in SjS plasma
(green arrows in Figure 3A). This green signal was not detected, as
expected, in HSG cells pre-incubated with monoclonal antibody
since the antibody was raised specifically for M3R.
To further verify the presence of anti-M3R autoantibodies in
SjS plasma, IgG was purified from five SjS plasma samples and
used as primary antibody in combination with commercially
available anti-M3R antibody. Figure 3B shows four representative
pictures of M3R and IgG staining on unfixed HSG cells taken at
a 6400 magnification. As shown in Figure 3B, red signals indicate
M3R staining on HSG cells (red arrows). Yellow colors indicate
co-localization of IgG and M3R (b, c, d, e, and h, yellow arrows).
Some staining showed M3R and IgG signal next to each other (a,
f, and g, white arrows). In addition, M3Rs formed a cluster (b, c, e
and h) with IgG. Interestingly, some of the IgG staining on the
HSG cells showed lack of co-localization with M3R (green
arrows). This result may suggest that SjS IgG binds to unidentified
receptors or proteins on the surface of HSG cells, indicating an
existence of other cell surface antigens in addition to M3R.

Figure 1. Increased membrane expression of GFP-taggedrecombinant human aquaporin 5 (rhAQP5) following carbachol
stimulation in HSG cells. (A) M3R expression was detected in HSG
cells (red color) using polyclonal (a, b) or monoclonal (c) antibody by
immunocytochemistry. Stained cells were observed at 6200 (a) and
6400 (b, c) magnifications. (B) hAQP5 protein expressions were
examined by western blotting in total HSG cell lysates purified from
non- or rhAQP5 vector-transfected HSG cells (a) and in HSG cell
membrane fractions purified from transfected cells with or without CCh
treatment (b) in duplicates #1 and #2. (C) To confirm the hAQP5
trafficking in HSG cells, control GFP (a) or rhAQP5 (c) vector transfected
HSG cells were treated with carbachol (CCh, 100 mM) (a and c) or no
stimulation (b). Images were taken under microscope with a 6400
magnification using a Zeiss Axiovert 200M microscope and obtained
with AxioVs40 software (Ver. 4.7.1.0, Zeiss).
doi:10.1371/journal.pone.0053113.g001

antagonists, 4-diphenyl-acetoxy-N-methyl-piperidine (4-DAMP) is
known as a M3R-specific antagonist for intracellular Ca2+
signaling cascade [9,11]. Nagy et al. has confirmed blocking
intracellular Ca2+ release by 4-DAMP against M3R in HSG cells
[27]. To verify AQP5 trafficking is mediated by CCh-induced
calcium release via M3R, rhAQP5 vector-transfected HSG cells
were pre-treated with 4-DAMP (10 mM) or prenzepine, M1R
specific antagonist, (10 mM), or 4-DAMP/prenzepine cocktail for
10 minutes. Then, cells were treated with CCh (100 mM) for
10 minutes and fixed with 4% of paraformaldehyde to examine
the AQP5 trafficking. hAQP5 trafficking in rhAQP5-HSG cells
after CCh stimulation in the presence or absence of M3R or M1R
antagonist (4-DAMP or prenzepine, respectively) was shown in
Figure 2A. To monitor or compare hAQP5 trafficking to the cell
membrane, original images with GFP signal in Figure 2A were
converted into ‘Fire’ 3D LUT (lookup tables) setting in ImageJ
software and only GFP signal above the fluorescent signal
threshold ($80, red or yellow color in converted picture), was
considered as a positive GFP signal. In Figure 2B, yellow arrows
indicate the positive GFP signal on the membrane and green
arrows indicate positive signals in the cytoplasm. Following CCh
stimulation, 4-DAMP pre-incubation suppressed hAQP5 trafficking to HSG cell membrane compared to AQP5 trafficking in the
control. The majority of HSG cells showed suppressed or inhibited
hAQP5 trafficking to plasma membrane with a small fraction of
cells exhibiting normal level of signal in the membrane. In
PLOS ONE | www.plosone.org

Anti-M3R autoantibody positive SjS plasma inhibited
carbachol-induced hAQP5 trafficking to the apical
membrane
Following verification of M3R expression and CCh-induced
rhAQP5 trafficking in HSG cells and the presence of anti-M3R
autoantibodies in patient plasma samples, healthy controls (HC)
and SjS plasma samples were screened for their ability to
translocate hAQP5 to the cell membrane. Transfected HSG cells
were pre-incubated with plasma from five HC or five SjS patients
for 24 hours. hAQP5 trafficking in rhAQP5-HSG cells after CCh
treatment was monitored by a confocal microscope (X630) for
10 minutes with 1/250 fixed exposure time. Images in Figure 4A
show representative and converted images of AQP5 trafficking in
HSG cells pre-incubated with HC, SjS plasma, or monoclonal
anti-M3R antibody (Figure 4A-(a), (b), or (c), respectively)
4
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Figure 2. Inhibition of hAQP5 trafficking in rhAQP5 vector-transfected HSG cells in the presence of 4-DAMP. (A) rhAQP5 vectortransfected HSG cells were stimulated with CCh (100 mM) in the presence or absence of 4-DAMP (10 mM), prenzepine (10 mM), and mixture of 4-DAMP
and prenzepine (M3R or M1R specific antagonist, respectively). (B) To monitor hAQP5 trafficking, original GFP pictures in (A) were converted into ‘Fire’
3D LUT (lookup tables) setting in ImageJ software and only GFP signal above the fluorescent signal threshold ($80, red or yellow color in converted
picture), was captured in (B) as positive GFP signal. Yellow arrows indicate the positive GFP signal on the membrane and green arrows indicates signal
in the cytoplasm in HSG cells. Cells were observed at 6200 magnification using a Zeiss Axiovert 200M microscope and images were obtained with
AxioVs40 software (Ver. 4.7.1.0, Zeiss).
doi:10.1371/journal.pone.0053113.g002

It has been known that the major signal transduction pathway
though M3R activation by carbachol treatment leads to increased
intracellular Ca2+ level. To test the impact of anti-M3R
autoantibodies on intracellular Ca2+ level upon CCh treatment,
rhAQP5-HSG cells were pre-incubated with media only (negative
control) or purified IgG from HC (10 mg/ml), SjS (10 mg/ml), or
monoclonal anti-M3R antibody (10 mg/ml) for 24 hours and
stimulated with carbachol (100 mM). As a positive control,
rhAQP5-HSG cells were incubated with ionomycin (100 mM) in
the absence of any IgG. As shown in Figure 5B, intracellular
calcium release in rhAQP5-HSG cells pre-incubated with IgG
from SjS was significantly reduced in comparison with cells preincubated with HC IgG. As expected, this suppression by SjS IgG
was also compatible with the cells pre-incubated with monoclonal
anti-M3R antibody.

following CCh stimulation. Quantification of these results
(Figure 4B) confirmed that CCh-induced hAQP5 trafficking was
observed as indicated by increased signal from approximately 58
to 78% in cells incubated with no-plasma or HC plasma (p,0.01,
Student’s t-test). However, HSG cells pre-incubated with SjS
plasma or monoclonal anti-M3R antibody showed reduced or
maintained signals (50 or 54%, respectively), less hAQP5
trafficking, with no statistical difference compared with non-CCh
treated rhAQP5-HSG (58%). These results indicate that autoantibodies in SjS patients’ plasma, which can bind to M3R, inhibit
hAQP5 trafficking from the cytoplasmic compartment to the
plasma membrane in HSG cells following agonist stimulation.

Anti-M3R autoantibody-positive SjS plasma inhibited
carbachol-induced intracellular calcium release in HSG
cells

SjS plasma inhibits CCh-induced cell volume decrease in
AQP5-GFP transfected HSG cells

To confirm the existence of autoantibodies that bind to M3R on
HSG cells by immunoprecipitation, commercially available HAtagged M3R expression vector was used to overexpress M3R in
HSG cells. Figure 5A shows, immunoprecipitation (IP)-Western
blot analysis using an extract of M3R-3xHA vector transfected
HSG cells with pooled plasma samples from HC or SjS. HAtagged M3R was detected by anti-HA antibody, showing a strong
band at 75 kDa on western blot. More interestingly, only SjS
plasma immunoprecipitated HA-tagged M3R, which was recognized by mouse monoclonal anti-HA antibody, compared to the
transfected cells pre-incubated with HC plasma.

PLOS ONE | www.plosone.org

In the same experimental set-up as above in Figure 4, we
observed unexpectedly that rhAQP5-HSG cells that were either
pre-incubated with HC plasma or only with media exhibited
decreased cell volume after CCh stimulation. However, SjS
plasma pre-treated rhAQP5-HSG cells stimulated with CCh
exhibited no significant cell volume change. The images from
confocal microscope before and 30 minutes after CCh treatment
on hAQP5-transfected HSG cells are presented in Figure 6A. For
image quantitation, the area of cross-section at the center of Z-axis
in the confocal image of the HSG cell was considered and
5
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Figure 3. Presence of anti-M3R autoantibodies in SjS plasma detected by immunocytochemistry. (A) HSG cells were pre-incubated with
(a) healthy control (HC) plasma, (b, e) Sjögren’s syndrome (SjS) plasma, (c) pre-absorbed SjS plasma, or (d) IgG depleted SjS plasma for 24 hours.
Endogenous expressions of M3R (red color) on HSG cells were detected by using poly- (a–d) or mono-(e) clonal antibody. Immunofluorescence
staining of HSG cells following pre-incubation with SjS plasma indicated co-localization [yellow or orange color in merged picture (b) and (e)] of
human IgG (green color) and M3R (red color) on HSG cells. This specific binding was confirmed by pre-absorbed (c), IgG depleted plasma (d), or
monoclonal antibody specific for M3R (e). Stained cells were observed at a 6200 magnification. (pM3R* Ab: polyclonal anti-hM3R antibody; mM3R
Ab: monoclonal anti-hM3R antibody). (B) HSG cells were incubated with purified IgG from five pooled-SjS plasma samples and polyclonal anti-M3R
antibody followed by Alexa Fluor 488 and 568-labeled secondary antibody incubation, respectively. Yellow (b, c, d, e, and h) or white arrows (a, f, and
g) in the image picture indicate co-localization or adjacent staining of IgG and M3R, respectively. poly a-M3R ab, polyclonal antibody; mono a-M3R
ab, monoclonal antibody; Green arrows, IgG staining; red arrows, M3R staining; white arrows, M3R and IgG adjacent staining; yellow arrows, colocalization of IgG and M3R. Cells were observed at 6400 magnification using a Zeiss Axiovert 200M microscope and images were obtained with
AxioVs40 software (Ver. 4.7.1.0, Zeiss).
doi:10.1371/journal.pone.0053113.g003

inhibited AQP5 trafficking, implying AQP5 trafficking to the
membrane is mainly mediated by M3R; 3) Anti-M3R autoantibodies and other cell surface antigen-specific antibodies are
present in SjS plasma or IgG; 4) AQP5 trafficking to the
membrane is suppressed when HSG cells were pre-incubated
with SjS plasma or SjS IgG prior to CCh treatment; 5) CChinduced volume reduction of AQP5 transfected cells are inhibited
by SjS plasma.
It has been proven that M3R stimulation by neurotransmitters
or CCh, non-selective agonist for MR, can increase intracellular
Ca2+ level in salivary gland acinar cells and HSG cells [27,31]. In
addition, Nagy et al. confirmed 4-DAMP blocked increase of free
intracellular Ca2+ level in CCh-treated HSG cells in a M3Rspecific manner [27]. In rat parotid glands, AQP5 was
translocated to the apical membrane with the treatment of
epinephrine and cevimeline, which also increase the intracellular
Ca2+ level [32,33]. Furthermore, rat AQP5 cDNA transfected
HSG cells were able to move AQP5 to the plasma membrane
when triggered by increased intracellular Ca2+ [15]. These studies
indicate increased intracellular Ca2+ level by agonist stimulation is
essential in translocating AQP5 to the cell membrane. To verify
the inhibitory effect of anti-M3R autoantibodies on AQP5

measured before and after CCh stimulation. Cross sectioned area
of each cells treated with CCh was normalized against the crosssectioned area of cells before CCh stimulation (Figure 6B).
rhAQP5-HSG cells pre-incubated with HC plasma decreased cell
volume by approximately 20% (Real-time image in Movie S1)
while transfected cells incubated with SjS showed negligible
volume change.

Discussion
Our previous studies and others’ have shown that circulating
autoantibodies specific for cell surface receptor M3R are one of
the important factors in the pathogenesis of secretory dysfunction
in SjS along with T- and B-cell infiltration in the exocrine glands
[6,29,30]. The purpose of this study was to further define the roles
of anti-M3R autoantibodies in SjS and their impact on AQP5
trafficking to the plasma membrane, which is critical for fluid
secretion in the salivary glands. Although previously reported data
showed discrepancies with respect to altered AQP5 trafficking in
the SjS salivary glands, our data demonstrated 1) Acetylcholine
receptor agonist CCh induced proper trafficking of human AQP5
in rhAQP5-vector transfected HSG cells; 2) Pre-incubation of
M3R specific antagonist, 4-DAMP, prior to CCh stimulation
PLOS ONE | www.plosone.org
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Figure 4. Inhibition of AQP5 trafficking to HSG cell plasma membrane by SjS plasma. (A) rhAQP5 vector transfected HSG cells were preincubated with five different healthy control (HC, (a)), five SjS plasma (b), or mono-clonal anti-M3R antibody (c) for 24 hours (only three representative
pictures are shown). rhAQP5 GFP signal trafficking in HSG cells after CCh treatment were acquired with a spinning disk confocal microscope with
a 63X oil-immersion objective, using a cascade-cooled EMCCD camera. HSG cells were observed at 30-second intervals for 15 minutes with 1/
250 second fixed exposure time. Representative still images were captured after 10 minutes and rhAQP5 signals were converted and analyzed by
ImageJ software (1.46a, open source software, http://rsb.info.nih.gov/ij/). Pictures were converted into ‘Fire’ 3D LUT (lookup tables) setting in ImageJ
software and only GFP signal above the fluorescent signal threshold ($80, red or yellow color in converted picture), was considered for quantitative
analysis (% of positive signal on the membrane) in (B) to compare rhAQP5 trafficking among CCh treated groups. Each column represents the mean
6 SEM of 5, p value less than 0.05 was considered significantly different by two-tailed unpaired Student’s t-test, **p,0.01.
doi:10.1371/journal.pone.0053113.g004

desensitize M3R signal pathway, which confirmed by functional
assays using carbachol-evoked responses of mouse-bladder smooth
muscle strips [6]. Interestingly, our study identified cell surface
antigen(s) other than M3R. To date, M3R is only cell surface
antigen known in SjS while all others are intracellular antigens.
Although identification of these cell surface antigens was not
further pursued in our study for it was not a scope of this study, it
would be important to characterize these cell surface antigen(s)
due to their potential roles in SjS pathogenesis.
Altered expression of AQP5 in the salivary glands of SjS has
been controversial. Immunofluorescence staining of AQP5 in
acinar cells showed impaired distribution; reduced at the apical
but increased at the basal membrane in SjS mouse (NOD) salivary
glands [23,34]. The treatment of purified SjS IgG to rat parotid
acinar cells confirmed reduced trafficking of AQP5 into the apical
membrane [5]. Abnormal distribution of AQP5 in minor salivary
gland [20] or defective cellular trafficking in lacrimal glands [21]
was also detected in SjS patients by immunohistochemical staining
using anti-human AQP5 antibody. However, a study reported that
there were no abnormal distributions of AQP5 detected in the
salivary and lacrimal glands of SjS patients when anti-rat AQP5
antibody was used [22]. Thus, detection of AQP5 expression to
the apical membrane appears to depend on the type of cell lines,
analysis methods, and sensitivity and specificity of antibodies.
To measure the effect of SjS autoantibodies on AQP5 more
directly, we monitored trafficking of AQP5 by expressing human

trafficking to the cell membrane of HSG cells, we stimulated the
transfected cells with CCh to increase intracellular Ca2+ and
monitored subsequent AQP5 trafficking in the presence or
absence of SjS plasma under a confocal imaging system.
In this current study, we confirmed the presence of M3R by
immunocytochemistry and semi-quantitative RT-PCR. M1R and
M3R mRNA both are endogenously expressed in HSG cells with
M3R more predominantly expressed. A monoclonal antibody
specific for the second extracellular loop of M3R also identified
M3R expression in our analyses. When the cell membrane fraction
was purified from the M3R transfected cells, expression of AQP5
was increased in the membrane upon carbachol treatment,
confirming the translocation of AQP5 to the cell surface. Blockage
of this process by a M3R inhibitor but not by a M1R inhibitor
clearly indicates that this trafficking is mainly mediated through
M3R. Throughout the study, we have used our threshold signal
value to define positive signal (A signal bar is provided in Figure
where appropriate). In addition, we identified five SjS plasma
samples that are positive for anti-M3R autoantibodies by coimmunostaining. The presence of IgG specific for cell surface
antigens were undetected after pre-absorption or IgG depletion as
indicted in our Figure 3. The specificity of these plasma samples
was further verified with our immunoprecipitation assay with HAtagged M3R and co-staining with monoclonal anti-M3R antibody.
These results support our previous findings where we showed that
anti-M3R antibodies in patients with primary Sjögren’s syndrome
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Figure 6. Inhibition of CCh-induced hAQP5-GFP transfected
HSG cell shrinkage by SjS plasma. (A) hAQP5-GFP transfected HSG
cells were pre-incubated with HC or SjS plasma for 24 hours and
stimulated with CCh. Representative still images were captured before
and after 30 minutes of CCh treatment. (B) Cell volume changes were
quantified by measuring the areas within the cell membrane before and
after CCh stimulation and normalized by the area before stimulation.
Cross section of the cell at center of z-axis was considered for the
analysis. Data are based on three independent experiments and all cells
under a microscopic view were counted for calculation each time. Each
column represents the mean 6 SEM, p value less than 0.05 was
considered significantly different by two-tailed unpaired Student’s ttest, *p,0.05.
doi:10.1371/journal.pone.0053113.g006

Figure 5. Reduced CCh-induced intracellular calcium releases
by SjS IgG. (A) Immunoprecipitation (IP)-Western blot analysis using
an extract of M3R-3xHA vector transfected HSG cells and pooled plasma
samples from five HC or SjS plasma demonstrated that IgG in SjS
plasma immunoprecipitated HA-tagged M3R (75 kDa), which was
recognized by mouse monoclonal anti-HA antibodies. (B) HSG cells
were pre-incubated with media only (negative control) or IgG from HC
(10 mg/ml), SjS (10 mg/ml) or monoclonal anti M3R antibody (10 mg/ml)
for 24 hours and treated with ionomycin (100 mM) or carbachol
(100 mM). Data are based on three independent experiments (n = 5).
Each column represents the mean 6 SEM, p value less than 0.05 was
considered significantly different by one-way ANOVA test.
doi:10.1371/journal.pone.0053113.g005

mention here to promote future studies. Roescher N et al. have
shown that there are limitations to detect anti-M3R autoantibodies
by using peptide-based ELISA system [37]. Thus, the development of reliable diagnostic tools for this antibody and further
investigations on the subject is imperative and will warrant their
associations with clinical symptoms.
One of the unexpected results was cell shrinkage observed with
CCh stimulation of hAQP5-GFP transfected HSG cells. The
transfected cells or the cells with HC plasma decreased cell volume
by about 20% following CCh stimulation. Interestingly, this
phenomenon was not observed in control GFP vector transfected
HSG cells, which do not over-expressing AQP5 (data not shown).
hAQP5-GFP transfected HSG cells slowly recovered the volume
after CCh stimulation and no cells were identified as apoptotic
during 45 minutes of monitoring, indicating cell shrinkage is not
due to cell death. In vivo (or ex vivo) studies using single salivary
gland acinar cell have shown that CCh induced intracellular Ca2+
release followed by cell shrinkage for the ion exchange and water
efflux [38,39]. However, HSG cells are known to be sensitive to
osmolality changes in the suspending medium but are insensitive
to cytoplasmic Ca2+ concentration [40,41]. Taken together, AQP5
must be present in order for HSG cells to shrink in response to
CCh stimulation and this process may not directly related to
cytoplasmic Ca2+ concentration but is associated with changes in
osmolality by CCh treatment. It has been reported that impaired
cell volume regulation and trafficking to apical membrane were
found in AQP5-deficient mice or cell lines [24,42,43]. Whether
the findings with HSG cells presented here (i.e., SjS plasma or IgG
suppresses CCh-induced cell volume change in AQP5-GFP
transfected HSG cells) would directly lead to clinical implications
is currently not known.
In conclusion, to understand one of the mechanisms of secretory
dysfunction in autoimmune SjS, we monitored trafficking of
human AQP5 in HSG cells following CCh stimulation in the
presence or absence of SjS plasma and verified SjS IgG specific for

AQP5 in a human cell line rather than measuring static expression
of AQP5. This is the first report to our knowledge that
demonstrates suppression of human AQP5 trafficking in the
presence of SjS autoantibodies. In our analyses, AQP5 trafficking
after CCh stimulation was greatly inhibited by pre-incubation with
SjS plasma while HC plasma had no effect in this process. This
effect was consistent with the cells pre-incubated with monoclonal
anti-M3R antibody specific for the second extracellular loop of
M3R in our experiment. This may imply that potential epitope(s)
that antibodies in SjS plasma used in our experiment recognize
may reside within the second extracellular loop of M3R as others
have suggested [8,28,35,36]. These results support our hypothesis
that salivary gland dysfunction in SjS is mediated, in part, through
the binding of anti-M3R autoantibodies to salivary gland acinar
cells, resulting in inhibition of intracellular Ca2+ release and
consequently AQP5 trafficking. It is presumed that since not all
patients are positive for anti-M3R antibodies, the contribution of
infiltrating cells in the glands to the loss of secretory function
would be more significant in patients who are negative for
autoantibodies whereas the roles of autoantibodies in dryness are
more prominent in patients who are negative for focal infiltration.
In addition, it is possible that patients who are positive for this
antibody may have more significant correlation with certain
clinical symptoms such as increased mild cognitive impairment or
over-reactive bladder symptoms due to the autoantibodies
targeting the receptors in the brain and the bladder, respectively.
These possibilities are highly speculative at this point due to
absence of specific and sensitive diagnostic assays but important to
PLOS ONE | www.plosone.org
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M3R and other unidentified surface antigens. The binding of the
autoantibodies to the receptor inhibited human AQP5 translocation to the plasma membrane. In addition, AQP5-overexpressed HSG cells decreased its volume following CCh
treatment only in AQP5 transfected cells, which was also
suppressed in the presence of SjS plasma. These alterations
caused by anti-M3R autoantibodies in SjS plasma or IgG may
play a critical role in secretory dysfunction in autoimmune SjS.
Furthermore, our current study emphasizes the importance of
future investigations on clinical associations between SjS symptoms, such as degree of secretory dysfunction, cognitive impairment, and/or bladder irritation, and different profiles (titers,
isotypes, and/or specificity) of anti-M3R autoantibodies in
individuals with SjS.

transfected HSG cells were pre-incubated with HC (A) or SjS (B)
plasma for 24 hours. (A) Strong yellow signal in the center of cells
was reduced as the orange signal on the membrane was increased
upon CCh stimulation of HC pre-incubated cells. (B) There was
no difference in signal detected before and after CCh stimulation
in the cytoplasm and the plasma membrane of SjS plasma
incubated cells. rhAQP5 GFP signal in HSG cells after CCh
treatment was acquired with a spinning disk confocal microscope
with a 63X oil-immersion objective, using a cascade-cooled
EMCCD camera. HSG cells were observed at 30-second intervals
for 30 minutes with 1/250 second fixed exposure time. Representative still images were captured after 0 and 30 minutes and
rhAQP5 signals were converted and analyzed by ImageJ software
(1.46a, open source software, http://rsb.info.nih.gov/ij/). Pictures
were converted into ‘Fire’ 3D LUT (lookup tables) setting and
signal spreading in a cell was measured with interactive 3D surface
plot v2.3.3 in ImageJ software.
(TIF)

Supporting Information
Figure S1 Dominant expression of muscarinic type 3
receptor in human salivary gland (HSG) cell line. MR
expression was measured in HSG cells by semi-quantitative RTPCR with M3R being the major subtype followed by M1R. M2R,
M4R, and M5R were not detected in HSG cells. Reverse
transcription polymerase chain reaction (RT-PCR) was performed
using primers as follows: M1R: forward: 59-TGGTGATCAAGATGCCAATGGTGG-39, reverse: 59-GAAGGCTTTGTTGCAGAGTGCGTA-39; M2R: forward: 59-CATATCCCGAGCCAGCAAGAGC-39,
reverse:
59GAGGCAACAGCACTGACTGAGG-39; M3R: forward: 59CGAGACGAGAGCCATCTACTCC-39, reverse: 59-GACCAGGGACATCCTTTTCCGC-39;
M4R:
forward:
59AGATTGTGACGAAGCAGACAGGCA,
reverse:
59TTTAAAGGTGGCGTTGCACAGAGC-39; M5R: 59-GACCAACAATGGCTGTCACAAGGT-39,
reverse:
59TCTGTTGCAGAGGGCATAGCAGAT-39. All primers used
in this study were obtained from Integrated DNA Technologies.
PCR conditions were 5 min at 95uC, (30 s at 95uC, 30 s at 57uC,
and 30 s at 72uC) 630 times, and 7 min at 72uC.
(TIF)

Movie S1 Increased expression of rhAQP5 on HSG cell
membrane and cell volume change following CCh
stimulation. (A) Live image of increased AQP5 expression on
the membrane of HSG cells and its shrinkage upon CCh
treatment. (B) Converted image of (A). (C) Live image of
transfected HSG cells pre-incubated with HC. (D) Live image of
transfected HSG cells pre-incubated with SjS plasma. Original live
images were converted into ‘Fire’ 3D LUT (lookup tables) setting
in ImageJ software.
(MOV)
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